TRPV4 ANTAGONISTS

A combination comprising a compound of Formula (I): or a pharmaceutically acceptable salt thereof; and one or more other therapeutic agents, selected from the group consisting of endothelin receptor antagonists, angiotensin converting enzyme (ACE) inhibitors, angiotension II receptor antagonists, va...

Full description

Saved in:
Bibliographic Details
Main Authors HAMMOND Marlys, PATTERSON Jaclyn R, STOY Patrick, CHEUNG Mui, GOODMAN Krista B, HOANG Tram H, EIDAM Hilary Schenck, HILFIKER Mark A, BROOKS Carl, YE Guosen
Format Patent
LanguageEnglish
Slovenian
Published 30.06.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:A combination comprising a compound of Formula (I): or a pharmaceutically acceptable salt thereof; and one or more other therapeutic agents, selected from the group consisting of endothelin receptor antagonists, angiotensin converting enzyme (ACE) inhibitors, angiotension II receptor antagonists, vasopeptidase inhibitors, vasopressin receptor modulators, diuretics, digoxin, beta blocker, aldosterone antagonists, iontropes, NSAIDS, nitric oxide donors, calcium channel modulators, muscarinic antagonists, steroidal anti-inflammatory drugs, bronchodilators, anti-histamines, leukotriene antagonist, HMG-CoA reductase inhibitors, dual non-selective ²-adrenoceptor and ± 1 -adrenoceptor antagonists, type-5 phosphodiesterase inhibitors, and renin inhibitors.
Bibliography:Application Number: SI20120030564